Cupps Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $2.22M | Buy |
43,902
+5
| +0% | +$253 | 0.96% | 27 |
|
|
2016
Q2 | $2M | Sell |
43,897
-54,738
| -55% | -$2.49M | 0.52% | 77 |
|
|
2016
Q1 | $3.9M | Sell |
98,635
-8,575
| -8% | -$339K | 0.74% | 54 |
|
|
2015
Q4 | $6.06M | Buy |
107,210
+47,745
| +80% | +$2.7M | 0.85% | 44 |
|
|
2015
Q3 | $2.37M | Buy |
+59,465
| New | +$2.37M | 0.31% | 93 |
|
|
2013
Q3 | – | Sell |
-431,896
| Closed | -$5.78M | – | 201 |
|
|
2013
Q2 | $5.78M | Buy |
+431,896
| New | +$5.78M | 0.46% | 62 |
|